Global Somatostatin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Somatostatin market size was valued at US$ 389 million in 2024 and is forecast to a readjusted size of USD 808 million by 2031 with a CAGR of 11.1% during review period.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.

China is the largest market, followed by Europe and India.

This report is a detailed and comprehensive analysis for global Somatostatin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Somatostatin market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031

Global Somatostatin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031

Global Somatostatin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031

Global Somatostatin market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Somatostatin

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Somatostatin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO, TianTaiShan, Yangtze River, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Somatostatin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
0.25mg/pcs
0.75mg/pcs
3mg/pcs

Market segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others

Major players covered
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Somatostatin product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales quantity, revenue, and global market share of Somatostatin from 2020 to 2025.

Chapter 3, the Somatostatin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Somatostatin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Somatostatin.

Chapter 14 and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion.